(4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol, 95.0%, 1g

2-Phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine hydrochloride, 98%, 5g

3-(2,5-Difluorobenzoyl)-4-methylpyridine, 97.0%, 1g

GC capillary column ROTI®Cap-5, 25 m, 0.25 mm, 0.10 µm, 1 Piece(s)

dihydro-3(2H)-thiophenone 1,1-dioxide, 95.0%, 5g

2H-Benzimidazol-2-one, 1,3-dihydro-5-[3-[4-(phenylmethyl)-1-piperidinyl]-1-propyn-1-yl]-, 98%, 25mg

2,2-dimethylhex-5-enoic acid, 95.0%, 250mg

4-Chloro-2-methylbenzenesulfonyl chloride, 95.0%, 250mg

N-Boc-DL-3-Cyanophenylalanine, 97.0%, 10g

4-Isopropylaniline>98.0%(GC)(T)500mL

BENZYL BENZODITHIOATE, 95.0%, 5g

4-(Bromomethyl)-1-chloro-2-methoxybenzene, 95.0%, 1g

(4-Benzyloxyphenyl)hydrazine, 95.0%, 5g